Pupillary Responses as a Biomarker of Early Risk for Alzheimer’s Disease
نویسندگان
چکیده
منابع مشابه
Role of microRNA as a biomarker in Alzheimer’s disease
Introduction: MicroRNAs are small, non-coding, and protected RNA molecules that regulate gene expression after transcription by mRNA degradation or inhibition of protein synthesis. The function of these molecules is critical to many cellular processes, including growth, development, differentiation, homeostasis, apoptosis, aging, stress resistance. In addition, some diseases including cancer, a...
متن کاملPupillary Light Reflex as an Objective Biomarker for Early Identification of Blast-Induced mTBI
During the last decade, the US military has experienced an increase in the incidence of traumatic brain injury (TBI) resulting from the use of explosive devices by enemy forces [1,2]. The Department of Defense (DoD) reported that 273,859 new cases of TBI have been clinically confirmed from 2000 to the first quarter of 2013, with mild TBI (mTBI) accounting for 82 percent of all cases [3]. Unfort...
متن کامل[18F]FDG-PET as a Biomarker for Early Alzheimer’s Disease
[ 18 Fluorine]fluorodeoxiglucose-Positron Emission Tomgraphy ( 18 F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complaints, notably Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). Together with morphological Magnetic Resonance Imaging (MRI) and cerebrospinal fluid biomarker assays it allows early identification of subjects with neurod...
متن کاملCan Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?
Introduction: As a glycoprotein, Plasma Prostate-Specific Antigen (PSA) is mainly produced by prostate epithelial cells and is used as a major diagnostic tool for prostate cancer. A group of researchers relate the elevated number of estrogen receptors in breast cancer samples to the over-production of PSA in this type of cancer. Therefore, the present study aimed to determine the participants' ...
متن کاملDNA Methylation as a Biomarker for Cardiovascular Disease Risk
BACKGROUND Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FINDINGS We examined the association between prevalence of CVD (myocardial infarction, stroke) and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Alzheimer's Disease
سال: 2017
ISSN: 1387-2877,1875-8908
DOI: 10.3233/jad-161078